Stinchcombe TE - Search Results

1

Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403.

Goldberg SB, Redman MW, Lilenbaum R, Politi K, Stinchcombe TE, Horn L, Chen EH, Mashru SH, Gettinger SN, Melnick MA, Herbst RS, Baumgart MA, Miao J, Moon J, Kelly K, Gandara DR. Goldberg SB, et al. Among authors: stinchcombe te. J Clin Oncol. 2020 Dec 1;38(34):4076-4085. doi: 10.1200/JCO.20.01149. Epub 2020 Oct 6. J Clin Oncol. 2020. PMID: 33021871 Free PMC article. Clinical Trial.

2

Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status.

Stinchcombe TE, Lee CB, Socinski MA. Stinchcombe TE, et al. Clin Lung Cancer. 2006 May;7 Suppl 4:S111-7. doi: 10.3816/clc.2006.s.002. Clin Lung Cancer. 2006. PMID: 16764751 Review.

3

Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan.

Stinchcombe TE, Socinski MA, Gangarosa LM, Khandani AH. Stinchcombe TE, et al. J Clin Oncol. 2006 Oct 20;24(30):4939-40. doi: 10.1200/JCO.2006.06.3354. J Clin Oncol. 2006. PMID: 17050879 No abstract available.

4

Radiation-induced sarcoma after high-dose thoracic radiation therapy in non-small-cell lung cancer.

Stinchcombe TE, Walters R, Khandani AH, Socinski MA. Stinchcombe TE, et al. J Clin Oncol. 2007 Apr 20;25(12):1621-3. doi: 10.1200/JCO.2006.10.3267. J Clin Oncol. 2007. PMID: 17443003 No abstract available.

5

Bevacizumab in the treatment of non-small-cell lung cancer.

Stinchcombe TE, Socinski MA. Stinchcombe TE, et al. Oncogene. 2007 May 28;26(25):3691-8. doi: 10.1038/sj.onc.1210366. Oncogene. 2007. PMID: 17530022 Review.

6

High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history.

O'Neil BH, Allen R, Spigel DR, Stinchcombe TE, Moore DT, Berlin JD, Goldberg RM. O'Neil BH, et al. Among authors: stinchcombe te. J Clin Oncol. 2007 Aug 20;25(24):3644-8. doi: 10.1200/JCO.2007.11.7812. J Clin Oncol. 2007. PMID: 17704414

7

Duration of first-line chemotherapy in advanced non small-cell lung cancer: less is more in the era of effective subsequent therapies.

Socinski MA, Stinchcombe TE. Socinski MA, et al. Among authors: stinchcombe te. J Clin Oncol. 2007 Nov 20;25(33):5155-7. doi: 10.1200/JCO.2007.13.4015. J Clin Oncol. 2007. PMID: 18024862 No abstract available.

8

The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer.

Stinchcombe TE, Harper HD, Hensing TA, Moore DT, Crane JM, Atkins JN, Willard EM, Detterbeck FC, Socinski MA. Stinchcombe TE, et al. J Thorac Oncol. 2008 Feb;3(2):145-51. doi: 10.1097/JTO.0b013e318160c5f1. J Thorac Oncol. 2008. PMID: 18303435 Free article. Clinical Trial.

9

Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.

Stinchcombe TE, Mauer AM, Hodgson LD, Herndon JE 2nd, Lynch TJ, Green MR, Vokes EE; Cancer and Leukemia Group B. Stinchcombe TE, et al. J Thorac Oncol. 2008 Nov;3(11):1301-7. doi: 10.1097/JTO.0b013e318187494a. J Thorac Oncol. 2008. PMID: 18978566 Free PMC article. Clinical Trial.

10

Treatment paradigms for advanced stage non-small cell lung cancer in the era of multiple lines of therapy.

Stinchcombe TE, Socinski MA. Stinchcombe TE, et al. J Thorac Oncol. 2009 Feb;4(2):243-50. doi: 10.1097/JTO.0b013e31819516a6. J Thorac Oncol. 2009. PMID: 19179904 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page